Market Closed -
Nyse
04:00:02 2024-04-30 pm EDT
|
5-day change
|
1st Jan Change
|
153.6
USD
|
-2.53%
|
|
-1.56%
|
-1.13%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
14,882
|
15,189
|
18,297
|
11,086
|
16,913
|
17,137
|
-
|
-
|
Enterprise Value (EV)
1 |
18,324
|
17,957
|
21,728
|
24,257
|
28,792
|
27,766
|
26,311
|
25,041
|
P/E ratio
|
18
x
|
7.76
x
|
9.97
x
|
5.9
x
|
8.67
x
|
14
x
|
11.2
x
|
11.5
x
|
Yield
|
1.95%
|
1.91%
|
1.62%
|
2.68%
|
1.8%
|
1.84%
|
1.9%
|
2.03%
|
Capitalization / Revenue
|
2.36
x
|
2.69
x
|
2.14
x
|
1.15
x
|
1.55
x
|
1.54
x
|
1.46
x
|
1.39
x
|
EV / Revenue
|
2.91
x
|
3.18
x
|
2.55
x
|
2.51
x
|
2.63
x
|
2.49
x
|
2.23
x
|
2.03
x
|
EV / EBITDA
|
10.2
x
|
12.2
x
|
7.66
x
|
9.27
x
|
11.8
x
|
10.2
x
|
8.75
x
|
8.05
x
|
EV / FCF
|
16.9
x
|
18.3
x
|
16.8
x
|
19
x
|
21.8
x
|
18.6
x
|
17.2
x
|
14.3
x
|
FCF Yield
|
5.92%
|
5.45%
|
5.94%
|
5.26%
|
4.58%
|
5.38%
|
5.8%
|
7%
|
Price to Book
|
5.91
x
|
4.34
x
|
4.33
x
|
1.97
x
|
2.4
x
|
2.09
x
|
1.84
x
|
1.62
x
|
Nbr of stocks (in thousands)
|
120,874
|
116,895
|
108,871
|
108,428
|
108,855
|
111,563
|
-
|
-
|
Reference price
2 |
123.1
|
129.9
|
168.1
|
102.2
|
155.4
|
153.6
|
153.6
|
153.6
|
Announcement Date
|
1/30/20
|
1/28/21
|
1/27/22
|
2/23/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
6,297
|
5,655
|
8,537
|
9,673
|
10,940
|
11,146
|
11,775
|
12,350
|
EBITDA
1 |
1,805
|
1,475
|
2,835
|
2,617
|
2,444
|
2,717
|
3,009
|
3,110
|
EBIT
1 |
1,476
|
1,131
|
2,473
|
2,171
|
1,753
|
1,976
|
2,249
|
2,450
|
Operating Margin
|
23.44%
|
20%
|
28.97%
|
22.44%
|
16.02%
|
17.72%
|
19.1%
|
19.84%
|
Earnings before Tax (EBT)
1 |
988
|
2,251
|
2,248
|
1,421
|
1,183
|
1,379
|
1,769
|
1,807
|
Net income
1 |
852
|
1,985
|
1,890
|
1,894
|
1,960
|
1,191
|
1,492
|
1,467
|
Net margin
|
13.53%
|
35.1%
|
22.14%
|
19.58%
|
17.92%
|
10.68%
|
12.67%
|
11.88%
|
EPS
2 |
6.840
|
16.75
|
16.86
|
17.34
|
17.92
|
10.98
|
13.76
|
13.33
|
Free Cash Flow
1 |
1,084
|
979
|
1,290
|
1,276
|
1,320
|
1,494
|
1,527
|
1,753
|
FCF margin
|
17.21%
|
17.31%
|
15.11%
|
13.19%
|
12.07%
|
13.4%
|
12.97%
|
14.2%
|
FCF Conversion (EBITDA)
|
60.06%
|
66.37%
|
45.5%
|
48.76%
|
54.01%
|
54.97%
|
50.76%
|
56.39%
|
FCF Conversion (Net income)
|
127.23%
|
49.32%
|
68.25%
|
67.37%
|
67.35%
|
125.44%
|
102.38%
|
119.54%
|
Dividend per Share
2 |
2.400
|
2.480
|
2.720
|
2.740
|
2.800
|
2.819
|
2.917
|
3.118
|
Announcement Date
|
1/30/20
|
1/28/21
|
1/27/22
|
2/23/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
2,266
|
2,275
|
2,538
|
2,486
|
2,301
|
2,348
|
2,853
|
2,795
|
2,723
|
2,569
|
2,684
|
2,836
|
2,852
|
2,721
|
2,851
|
EBITDA
1 |
739
|
745
|
813
|
744
|
607
|
453
|
596
|
616
|
624
|
608
|
574.7
|
693.8
|
741.5
|
707.4
|
714.2
|
EBIT
1 |
648
|
652
|
713
|
646
|
510
|
302
|
424
|
444
|
451
|
434
|
394.5
|
510.4
|
553.8
|
522.4
|
553.6
|
Operating Margin
|
28.6%
|
28.66%
|
28.09%
|
25.99%
|
22.16%
|
12.86%
|
14.86%
|
15.89%
|
16.56%
|
16.89%
|
14.7%
|
18%
|
19.42%
|
19.2%
|
19.42%
|
Earnings before Tax (EBT)
1 |
622
|
557
|
616
|
554
|
321
|
-70
|
121
|
216
|
714
|
132
|
226.3
|
354
|
410.3
|
388.3
|
392.5
|
Net income
1 |
506
|
524
|
502
|
434
|
191
|
767
|
91
|
219
|
951
|
698
|
202
|
311
|
360.2
|
338.2
|
351.5
|
Net margin
|
22.33%
|
23.03%
|
19.78%
|
17.46%
|
8.3%
|
32.67%
|
3.19%
|
7.84%
|
34.92%
|
27.17%
|
7.53%
|
10.97%
|
12.63%
|
12.43%
|
12.33%
|
EPS
2 |
4.560
|
4.790
|
4.610
|
3.980
|
1.750
|
7.030
|
0.8300
|
2.000
|
8.690
|
6.370
|
1.851
|
2.861
|
3.342
|
3.158
|
3.220
|
Dividend per Share
2 |
0.6800
|
0.6800
|
0.6800
|
0.6800
|
0.6800
|
0.7000
|
0.7000
|
0.7000
|
-
|
0.7000
|
0.6967
|
0.7000
|
0.7083
|
0.7200
|
0.7167
|
Announcement Date
|
10/21/21
|
1/27/22
|
4/28/22
|
7/28/22
|
11/3/22
|
2/23/23
|
5/9/23
|
8/7/23
|
11/6/23
|
2/20/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
3,442
|
2,768
|
3,431
|
13,171
|
11,879
|
10,629
|
9,174
|
7,904
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.907
x
|
1.877
x
|
1.21
x
|
5.033
x
|
4.86
x
|
3.912
x
|
3.049
x
|
2.542
x
|
Free Cash Flow
1 |
1,084
|
979
|
1,290
|
1,276
|
1,320
|
1,494
|
1,527
|
1,753
|
ROE (net income / shareholders' equity)
|
43.3%
|
30%
|
52.7%
|
35.3%
|
15.3%
|
16.5%
|
17.9%
|
17.6%
|
ROA (Net income/ Total Assets)
|
9.07%
|
19.5%
|
16.5%
|
9.07%
|
3.69%
|
4.61%
|
5.61%
|
6.17%
|
Assets
1 |
9,395
|
10,193
|
11,442
|
20,888
|
53,086
|
25,810
|
26,590
|
23,767
|
Book Value Per Share
2 |
20.80
|
29.90
|
38.80
|
52.00
|
64.80
|
73.60
|
83.40
|
94.70
|
Cash Flow per Share
2 |
11.70
|
11.30
|
15.70
|
16.70
|
17.40
|
16.90
|
19.10
|
21.80
|
Capex
1 |
370
|
364
|
467
|
543
|
568
|
427
|
493
|
529
|
Capex / Sales
|
5.88%
|
6.44%
|
5.47%
|
5.61%
|
5.19%
|
3.83%
|
4.18%
|
4.28%
|
Announcement Date
|
1/30/20
|
1/28/21
|
1/27/22
|
2/23/23
|
2/20/24
|
-
|
-
|
-
|
Last Close Price
153.6
USD Average target price
162.2
USD Spread / Average Target +5.61% Consensus |
1st Jan change
|
Capi.
|
---|
| -1.13% | 17.58B | | +14.02% | 63.38B | | -3.80% | 46.51B | | +13.26% | 39.91B | | +18.33% | 25.57B | | +8.22% | 18.95B | | -21.03% | 16.1B | | +1.06% | 14.98B | | -16.73% | 14.78B | | -24.13% | 13.48B |
Other Specialty Chemicals
|